Premier Alternatives

Ruby Bio

Oakland, CA · Founded 2022 · Privately Held (backing)

Developer of a biomanufacturing platform intended for producing bio-based chemicals and ingredients from renewable feedstocks. Ruby Bio is based in Oakland, CA and was founded in 2022. It was valued at $24 million at its seed round in Jun 2025, the last priced event on record. It has raised $8 million across 2 recorded rounds; the latest was an $8 million early-stage round in May 2025.

PMV mark · valuation
$24.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$8.0M
Last round
Early Stage VC
May 2025

Ruby Bio key facts

as of Oct 2026
  • Developer of a biomanufacturing platform intended for producing bio-based chemicals and ingredients from renewable feedstocks.
  • Ruby Bio is valued at approximately $24.0M as of Oct 2026, set at its seed round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $8.0M across 2 recorded rounds; the latest was Early Stage VC ($8.0M) in May 2025.
  • Notable investors include Alumni Ventures, gener8tor, Joyance Partners, Dhuna Ventures, Fusion Fund — 12 tracked in total.
  • Ruby Bio has filed 3 Form Ds with the SEC since 2022, most recently Jun 2025 ($8.0M sold to 22 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$24.0M

Valued at $24.0M at its seed round, Jun 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Ruby Bio with a free account
  • ·The complete investor list: 12 names
  • ·Watch Ruby Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ruby Bio funding rounds

2 rounds
May 2025Early Stage VC$8.0MSEC filing▮
Sep 2022Early Stage VC$5.1MSEC filing▮
Full funding history →

Ruby Bio valuation

Ruby Bio was valued at $24 million at its seed round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Ruby Bio raised?

Ruby Bio has raised $8 million across 2 recorded rounds since 2022. The largest was an $8 million early-stage round in May 2025.

Ruby Bio has filed 3 Form Ds with the SEC since 2022, most recently in Jun 2025 ($8 million sold to 22 investors).

Ruby Bio investors

12 investors are on record for Ruby Bio, including Alumni Ventures, gener8tor, Joyance Partners and Dhuna Ventures. By type, the record holds 5 venture capital firms. The early-stage round in May 2025 drew 22 investors.

About Ruby Bio

Developer of a biomanufacturing platform intended for producing bio-based chemicals and ingredients from renewable feedstocks. The company's platform uses yeast-based fermentation to convert sugar and waste-derived inputs into biodegradable molecules, including biosurfactants, food emulsifiers, polyol sweeteners, biomonomers for polymers, and fermentation-derived oleochemicals, enabling manufacturers to obtain bio-based ingredients and chemical substitutes for industrial and consumer product applications.

Sector
Business Products and Services (B2B)
HQ
Oakland, CA, United States
Founded
2022
Employees
10
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.